Drug Interactions Database

3916 interactions from BNF 85 - Check your medicines

Source: BNF 85
orangejuice celiprolol

decreases exposure

Unknown
oritavancin coumarins

increases exposure

Unknown Theoretical
oritavancin warfarin

increases exposure

Unknown Theoretical
osilodrostat agomelatine

increases exposure

Unknown Study
osilodrostat anaesthetics,local

increases exposure

Unknown Theoretical
osilodrostat anagrelide

increases exposure

Unknown Theoretical
osilodrostat chlorpromazine

increases exposure

Unknown Theoretical
osilodrostat duloxetine

increases exposure

Unknown Theoretical
osilodrostat loxapine

increases exposure

Unknown Theoretical
osilodrostat melatonin

increases exposure

Unknown Theoretical
osilodrostat phenothiazines

increases exposure

Unknown Theoretical
osilodrostat phosphodiesterasetype-

increases exposure

Unknown Theoretical
osilodrostat rasagiline

increases exposure

Unknown Study
osilodrostat riluzole

increases exposure

Unknown Theoretical
osilodrostat roflumilast

increases exposure

Unknown Theoretical
osilodrostat ropivacaine

increases exposure

Unknown Theoretical
osilodrostat triptans

increases exposure

Unknown Theoretical
osilodrostat zolmitriptan

increases exposure

Unknown Theoretical
osimertinib aliskiren

increases exposure

Unknown Study
osimertinib antihistamines,non-sedating

increases exposure

Unknown Study
osimertinib colchicine

increases exposure

Unknown Study
osimertinib dabigatran

increases exposure

Unknown Study
osimertinib digoxin

increases exposure

Unknown Study
osimertinib docetaxel

increases exposure

Unknown Study
osimertinib everolimus

increases exposure

Unknown Study
osimertinib fexofenadine

increases exposure

Unknown Study
osimertinib loperamide

increases exposure

Unknown Study
osimertinib paclitaxel

increases exposure

Unknown Study
osimertinib sirolimus

increases exposure

Unknown Study
osimertinib talazoparib

increases exposure

Unknown Study
osimertinib taxanes

increases exposure

Unknown Study
osimertinib thrombininhibitors

increases exposure

Unknown Study
osimertinib topotecan

increases exposure

Unknown Study
oxcarbazepine atorvastatin

decreases exposure

Unknown Theoretical
oxcarbazepine ciclosporin

decreases concentration

Unknown Anecdotal
oxcarbazepine dolutegravir

decreases exposure

Unknown Theoretical
oxcarbazepine erlotinib

decreases exposure

Unknown Study
oxcarbazepine gefitinib

decreases exposure

Unknown Study
oxcarbazepine simvastatin

decreases exposure

Unknown Theoretical
oxcarbazepine sorafenib

decreases exposure

Unknown Study
oxcarbazepine statins

decreases exposure

Unknown Theoretical
oxybutynin zonisamide

increases risk of overheatinganddehydration

Unknown Theoretical
oxymetholone coumarins

increases anticoagulant effect

Unknown Anecdotal
oxymetholone phenindione

increases anticoagulant effect

Unknown Anecdotal
ozanimod theactivemetabolitesofozanimod

increases exposure

Unknown Theoretical
palbociclib benzodiazepines

increases exposure

Unknown Study
palbociclib midazolam

increases exposure

Unknown Study
pancreatin acarbose

decreases effects

Unknown Theoretical
pancuronium digoxin

increases risk of cardiovascularadverseeffects

Unknown Anecdotal
pantoprazole alpelisib

increases exposure

Unknown Theoretical
Important: This database uses data from the British National Formulary (BNF 85). It is for informational purposes only and is not a substitute for professional medical advice.